High Throughput Sciences
高通量科学
基本信息
- 批准号:10617303
- 负责人:
- 金额:$ 22.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-06-17 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Biocompatible MaterialsBioinformaticsBiologicalBiological AssayBudgetsCancer CenterCancer Center Support GrantCell LineCellsChIP-seqClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCollectionConsultationsCore FacilityCustomDataData AnalysesData SetDevelopmentDrug Delivery SystemsEducationEducational workshopEnzyme-Linked Immunosorbent AssayEquipmentEvaluationFundingGeneticGenomicsImageImaging technologyInformation CentersInstitutionLibrariesLibrary MaterialsLiquid substanceMethodsMissionMusMycoplasmaPreparationResearchResearch PersonnelResource SharingResourcesRoboticsRoleSamplingScienceSeriesServicesSourceStainsSystemSystems BiologyTechnologyTestingToxicologyTrainingValidationZebrafishassay developmentdesigndrug discoveryexomegene discoveryinstrumentationinterestlight scatteringmachine learning algorithmmemberprogramsresponsescreeningsmall moleculesmall molecule librariessuccesstechnology platformtissue processingtooltraining opportunity
项目摘要
High Throughput Sciences Core: Project Summary/Abstract
The Koch Institute High Throughput Sciences Core (HTS Core) provides automated technologies, expertise and
training that allows Cancer Center Members to investigate the interplay between biomaterials, biomolecules, small
molecules and cells in a high-throughput, multiplexed manner to enable drug and gene discovery, drug delivery,
toxicology, and systems biology applications. The HTS Core possesses state-of-the-art robotic instrumentation, an
array of biological tools, including validated cell lines and curated libraries, and an exceptional staff with expertise in
assay development and adaptation, screening execution, and robotics workflows. HTS Core activities were
established in 2011, with support from CCSG Developmental Funds and Institutional support. In the prior
submission, HTS activities were embedded in the Koch Institute Genomics Core, reflecting their extensive
interactions. During this current period, the HTS Core has greatly expanded its roles and impact for both Center
Members and other Koch Institute Cores. Given this, and on the advice of our SAB, we are requesting funding for
High Throughput Sciences as a stand-alone Core.
In the current funding period, the HTS Core added a significant number of new capabilities and modified existing
services, including: a new high throughput flow cytometer and tissue processing equipment; added >55,000 new
compounds to small molecule libraries; automated workflows for ELISAs, high content imaging and HT sample
preparation pipelines, including automated plate-based HT ChIP-Seq sample preparation (collaborating with the
Integrated Genomics & Bioinformatics Core); and cell line management services, including mycoplasma testing and
banking of mycoplasma-free cell lines. Center Member Core use has been strong: 66% of Center Members use the
Core, account for 73% of Core service use, and include investigators from all three Research Programs.
In the upcoming period, the HTS Core will continue to offer a wide range of state-of-the-art services to support
Center Member research programs, and will evaluate emerging capabilities in the context of Center Member needs
and interests. A number of new initiatives are planned, including: acquisition and evaluation of new equipment;
upgrades to existing equipment; acquisition of new CRISPR and targeted small molecule libraries; establishment of
small molecule screening in zebrafish; continued collaboration with other Koch Institute Core Facilities to develop
technology and streamline workflows; deployment of a custom-built LIMS system to manage library materials and
screening assay data; dataset sharing to support development of machine learning algorithms; and collaborating
with other Koch Institute Cores to develop a monthly workshop series to support Center Members’ access to
imaging technology platforms and data analysis. This Shared Resource is essential to the success of the Koch
Institute mission and provides exceptional value to the CCSG. The requested CCSG budget for Year 49 is
increased by 1.6% over the Core CCSG budget for the current period (Year 48).
高通量科学核心:项目摘要/摘要
科赫研究所高通量科学核心(HTS Core)提供自动化技术、专业知识和
允许癌症中心成员调查生物材料、生物分子、小分子之间的相互作用的培训
以高通量、多重方式分析分子和细胞,以实现药物和基因发现、药物输送、
HTS Core 拥有最先进的机器人仪器、毒理学和系统生物学应用。
一系列生物工具,包括经过验证的细胞系和精选的文库,以及具有以下专业知识的优秀员工
分析开发和适应、筛选执行和机器人技术工作流程。
成立于 2011 年,得到 CCSG 发展基金和机构的支持。
根据提交的材料,HTS 活动被嵌入到科赫研究所基因组学核心中,反映了其广泛的
在此期间,HTS 核心极大地扩展了其对两个中心的作用和影响。
鉴于此,根据我们的 SAB 的建议,我们正在请求资金。
高通量科学作为独立的核心。
在当前资助期内,HTS Core 添加了大量新功能并修改了现有功能
服务,包括:新增超过 55,000 台新型高通量流式细胞仪和组织处理设备;
化合物到小分子库;ELISA、高内涵成像和 HT 样品的自动化工作流程
制备流程,包括基于板的自动化 HT ChIP-Seq 样品制备(与
综合基因组学和生物信息学核心)和细胞系管理服务,包括支原体检测和
无支原体细胞系的银行库中心成员核心使用率很高:66% 的中心成员使用该系统。
核心,占核心服务使用的 73%,包括来自所有三个研究计划的研究人员。
在接下来的一段时间内,HTS Core 将继续提供广泛的最先进的服务来支持
中心成员研究计划,并将根据中心成员需求评估新兴能力
计划采取一些新举措,包括:新设备的采购和评估;
升级现有设备;购买新的CRISPR和靶向小分子库;
斑马鱼小分子筛选;继续与科赫研究所其他核心设施合作开发
技术并简化工作流程;部署定制的 LIMS 系统来管理图书馆资料和
筛选分析数据;数据集共享以支持机器学习算法的开发和协作;
与其他科赫研究所核心人员一起开发每月研讨会系列,以支持中心成员获得
该共享资源对于科赫的成功至关重要。
制定使命并为 CCSG 提供非凡价值 要求的第 49 年 CCSG 预算为:
比本期(第 48 年)核心 CCSG 预算增加 1.6%。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Angela Nicole Koehler其他文献
Angela Nicole Koehler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Angela Nicole Koehler', 18)}}的其他基金
Developing Direct Small-Molecule Probes of Myc-Dependent Transcription
开发 Myc 依赖性转录的直接小分子探针
- 批准号:
8826461 - 财政年份:2014
- 资助金额:
$ 22.14万 - 项目类别:
Developing Direct Small-Molecule Probes of Myc-Dependent Transcription
开发 Myc 依赖性转录的直接小分子探针
- 批准号:
8507177 - 财政年份:2012
- 资助金额:
$ 22.14万 - 项目类别:
Developing Direct Small-Molecule Probes of Myc-Dependent Transcription
开发 Myc 依赖性转录的直接小分子探针
- 批准号:
8372920 - 财政年份:2012
- 资助金额:
$ 22.14万 - 项目类别:
相似国自然基金
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
- 批准号:32300528
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
- 批准号:82301786
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
- 批准号:62373216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
- 批准号:32370698
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
相似海外基金
Age and sex differences in the immune response to synthetic materials
对合成材料的免疫反应存在年龄和性别差异
- 批准号:
10644064 - 财政年份:2023
- 资助金额:
$ 22.14万 - 项目类别:
Core B: Biorepository and Biospecimen Resource Facility Core
核心 B:生物样本库和生物样本资源设施核心
- 批准号:
10630467 - 财政年份:2023
- 资助金额:
$ 22.14万 - 项目类别:
Impact of Titanium-mediated Oxidative Stress on LPS/TLR4 Signaling
钛介导的氧化应激对 LPS/TLR4 信号传导的影响
- 批准号:
10827025 - 财政年份:2023
- 资助金额:
$ 22.14万 - 项目类别:
Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity
基质粘弹性对贴壁细胞增殖的调节
- 批准号:
10735701 - 财政年份:2023
- 资助金额:
$ 22.14万 - 项目类别: